相关实验视频

Updated: Jan 9, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

全球皮铁与阿尔茨海默氏症的认知障碍有关:基于MRI的元分析证据

Marthe Mieling¹, Clara Wiskow¹, Nico Bunzeck^1,2

¹Department of Psychology, University of Lübeck, Lübeck, Germany.

Annals of the New York Academy of Sciences

|December 4, 2025

概括

这次元分析发现,与健康对照人群相比,阿尔茨海默病 (AD) 患者的大脑铁含量更高. 基底质结构中铁的升高是阿尔茨海默病的关键特征,影响认知功能.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
医疗成像医学成像

背景情况:

铁对大脑功能至关重要,但过量的铁可以损害认知过程,特别是在衰老过程中.
虽然单独的研究表明铁和阿尔茨海默病 (AD) 之间存在联系,但缺乏强有力的元分析证据.

研究的目的:

与健康对照组 (HC) 相比,对阿尔茨海默病 (AD) 患者的大脑中铁含量进行元分析.
探索在AD患者中特定大脑区域的铁积累与认知表现之间的关系.

主要方法:

一项对23项磁共振成像 (MRI) 研究的元分析,涉及715名AD患者和1130名HC患者.
对铁敏感的标记物被测量在基底,丘脑和海马.
认知表现使用迷你精神状态检查 (MMSE) 进行评估.

主要成果:

与HC相比,AD患者在所有研究的大脑区域中观察到明显更高的铁含量.
铁的最实质性的增加是在膜和尾状核中发现的.
在阿尔茨海默病患者中,球体中的铁含量与MMSE得分呈负相关性.

结论:

增加的铁含量,特别是在基底质结构中,对于认知处理至关重要,是阿尔茨海默病的决定性特征.
这些发现凸显了铁失调在AD病理生理学和认知衰退中的作用.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.这就是为什么MRI是MRI.基底性腺 (Basal Ganglia) 是一个认知表现认知表现铁是铁,铁是铁,铁是铁.这是一个元分析.

更多相关视频

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...